187 related articles for article (PubMed ID: 16400190)
1. Atm-haploinsufficiency enhances susceptibility to carcinogen-induced mammary tumors.
Lu S; Shen K; Wang Y; Santner SJ; Chen J; Brooks SC; Wang YA
Carcinogenesis; 2006 Apr; 27(4):848-55. PubMed ID: 16400190
[TBL] [Abstract][Full Text] [Related]
2. Atm heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice.
Umesako S; Fujisawa K; Iiga S; Mori N; Takahashi M; Hong DP; Song CW; Haga S; Imai S; Niwa O; Okumoto M
Breast Cancer Res; 2005; 7(1):R164-70. PubMed ID: 15642165
[TBL] [Abstract][Full Text] [Related]
3. Ataxia telangiectasia-mutated and p53 are potential mediators of chloroquine-induced resistance to mammary carcinogenesis.
Loehberg CR; Thompson T; Kastan MB; Maclean KH; Edwards DG; Kittrell FS; Medina D; Conneely OM; O'Malley BW
Cancer Res; 2007 Dec; 67(24):12026-33. PubMed ID: 18089834
[TBL] [Abstract][Full Text] [Related]
4. Contribution of mutations in ATM to breast cancer development in the Czech population.
Soukupova J; Dundr P; Kleibl Z; Pohlreich P
Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957
[TBL] [Abstract][Full Text] [Related]
5. Atm heterozygosity does not increase tumor susceptibility to ionizing radiation alone or in a p53 heterozygous background.
Mao JH; Wu D; DelRosario R; Castellanos A; Balmain A; Perez-Losada J
Oncogene; 2008 Nov; 27(51):6596-600. PubMed ID: 18679420
[TBL] [Abstract][Full Text] [Related]
6. Atm haploinsufficiency does not affect ionizing radiation mutagenesis in solid mouse tissues.
Connolly L; Lasarev M; Jordan R; Schwartz JL; Turker MS
Radiat Res; 2006 Jul; 166(1 Pt 1):39-46. PubMed ID: 16808618
[TBL] [Abstract][Full Text] [Related]
7. ATM and breast cancer susceptibility.
Ahmed M; Rahman N
Oncogene; 2006 Sep; 25(43):5906-11. PubMed ID: 16998505
[TBL] [Abstract][Full Text] [Related]
8. ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.
Paglia LL; Laugé A; Weber J; Champ J; Cavaciuti E; Russo A; Viovy JL; Stoppa-Lyonnet D
Breast Cancer Res Treat; 2010 Jan; 119(2):443-52. PubMed ID: 19404735
[TBL] [Abstract][Full Text] [Related]
9. Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer.
Spring K; Ahangari F; Scott SP; Waring P; Purdie DM; Chen PC; Hourigan K; Ramsay J; McKinnon PJ; Swift M; Lavin MF
Nat Genet; 2002 Sep; 32(1):185-90. PubMed ID: 12195425
[TBL] [Abstract][Full Text] [Related]
10. Atm heterozygosity cooperates with loss of Brca1 to increase the severity of mammary gland cancer and reduce ductal branching.
Bowen TJ; Yakushiji H; Montagna C; Jain S; Ried T; Wynshaw-Boris A
Cancer Res; 2005 Oct; 65(19):8736-46. PubMed ID: 16204043
[TBL] [Abstract][Full Text] [Related]
11. [Ataxia-telangiectasia mutated gene and breast cancer susceptibility].
Zhang N; Che J; Bai S; Wu Z; Cui Y; Zou W
Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):9-15. PubMed ID: 20353086
[TBL] [Abstract][Full Text] [Related]
12. The ATM gene and ataxia telangiectasia.
Mavrou A; Tsangaris GT; Roma E; Kolialexi A
Anticancer Res; 2008; 28(1B):401-5. PubMed ID: 18383876
[TBL] [Abstract][Full Text] [Related]
13. Association between polymorphisms of the ataxia telangiectasia mutated gene and breast cancer risk: evidence from the current studies.
Lu PH; Wei MX; Si SP; Liu X; Shen W; Tao GQ; Chen MB
Breast Cancer Res Treat; 2011 Feb; 126(1):141-8. PubMed ID: 20665102
[TBL] [Abstract][Full Text] [Related]
14. Germline ATM mutational analysis in BRCA1/BRCA2 negative hereditary breast cancer families by MALDI-TOF mass spectrometry.
Graña B; Fachal L; Darder E; Balmaña J; Ramón Y Cajal T; Blanco I; Torres A; Lázaro C; Diez O; Alonso C; Santamariña M; Velasco A; Teulé A; Lasa A; Blanco A; Izquierdo A; Borràs J; Gutiérrez-Enríquez S; Vega A; Brunet J
Breast Cancer Res Treat; 2011 Jul; 128(2):573-9. PubMed ID: 21445571
[TBL] [Abstract][Full Text] [Related]
15. Risk of cancer by ATM missense mutations in the general population.
Dombernowsky SL; Weischer M; Allin KH; Bojesen SE; Tybjaerg-Hansen A; Nordestgaard BG
J Clin Oncol; 2008 Jun; 26(18):3057-62. PubMed ID: 18565893
[TBL] [Abstract][Full Text] [Related]
16. Detection of ATM gene mutations in young lung cancer patients: a population-based control study.
Schneider J; Illig T; Rosenberger A; Bickeböller H; Wichmann HE
Arch Med Res; 2008 Feb; 39(2):226-31. PubMed ID: 18164969
[TBL] [Abstract][Full Text] [Related]
17. Two ATM variants and breast cancer risk.
Thompson D; Antoniou AC; Jenkins M; Marsh A; Chen X; Wayne T; Tesoriero A; Milne R; Spurdle A; Thorstenson Y; Southey M; Giles GG; Khanna KK; Sambrook J; Oefner P; Goldgar D; Hopper JL; Easton D; Chenevix-Trench G;
Hum Mutat; 2005 Jun; 25(6):594-5. PubMed ID: 15880680
[TBL] [Abstract][Full Text] [Related]
18. ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1/BRCA2 mutations.
Brunet J; Gutiérrez-Enríquez S; Torres A; Bérez V; Sanjosé S; Galceran J; Izquierdo A; Menéndez JA; Gumà J; Borràs J
Clin Genet; 2008 May; 73(5):465-73. PubMed ID: 18384426
[TBL] [Abstract][Full Text] [Related]
19. Histopathological features of breast cancer in carriers of ATM gene variants.
Balleine RL; Murali R; Bilous AM; Farshid G; Waring P; Provan P; Byth K; Thorne H; ; Kirk JA
Histopathology; 2006 Nov; 49(5):523-32. PubMed ID: 17064299
[TBL] [Abstract][Full Text] [Related]
20. ATM mutations in cancer families.
Vorechovský I; Luo L; Lindblom A; Negrini M; Webster AD; Croce CM; Hammarström L
Cancer Res; 1996 Sep; 56(18):4130-3. PubMed ID: 8797579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
